Zimmer Biomet Holdings Inc [ZBH] stock is trading at $104.00, down -0.67%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ZBH shares have lost -0.91% over the last week, with a monthly amount drifted -2.35%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Piper Sandler downgraded its rating to Neutral on July 01, 2024, and dropped its price target to $115. On May 30, 2024, Goldman initiated with a Neutral rating and assigned a price target of $129 on the stock. Argus upgraded its rating to a Buy but stick to its price target of $150 on May 21, 2024. Evercore ISI downgraded its rating to a In-line and reduced its price target to $125 on January 04, 2024. ROTH MKM started tracking with a Neutral rating for this stock on October 20, 2023, and assigned it a price target of $120. In a note dated August 28, 2023, BTIG Research upgraded an Buy rating on this stock but restated the target price of $139.
Zimmer Biomet Holdings Inc [ZBH] stock has fluctuated between $101.47 and $133.90 over the past year. Currently, Wall Street analysts expect the stock to reach $133.57 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $104.00 at the most recent close of the market. An investor can expect a potential return of 28.43% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
Zimmer Biomet Holdings Inc [NYSE:ZBH] reported sales of 7.52B for the trailing twelve months, which represents a growth of 3.87%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.08 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 103.41 points at the first support level, and at 102.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 105.06, and for the 2nd resistance point, it is at 106.11.
Ratios To Look Out For
For context, Zimmer Biomet Holdings Inc’s Current Ratio is 1.29. In addition, the Quick Ratio stands at 0.63 and the Cash Ratio stands at 0.12. Considering the valuation of this stock, the price to sales ratio is 2.81, the price to book ratio is 1.67 and price to earnings (TTM) ratio is 21.68.
Transactions by insiders
Recent insider trading involved Yi Sang, Group President, Asia Pacific, that happened on May 31 ’24 when 12857.0 shares were sold. Group President, Asia Pacific, Yi Sang completed a deal on Mar 07 ’24 to sell 1705.0 shares. Meanwhile, Sr. VP/Gen Counsel/Secretary Phipps Chad F sold 26156.0 shares on Feb 22 ’24.
